UW Center for Commercialization: Express Licenses: Drug Interaction Database
Drug Interaction Database
The Metabolism and Transport Drug Interaction Database was developed in the Department of Pharmaceutics, School of Pharmacy at the University of Washington. The purpose of this project is to provide an analysis tool for scientific researchers and clinicians that allows them to discover correlations among the huge amount of drug research findings available. The user can search the database using a number of standard or customized queries and approach the data from many different perspectives. The database is Web-based, and is regularly updated by the Drug Interaction Database staff. read more
Screenshots
Form detailed queries
Sort through results at a glance
Description of Data
The Drug Interaction Database is based upon original research articles that have been categorized by:
- in vivo information such as pharmacokinetic interactions, pharmacodynamic interactions, clinical case reports, and single-drug pharmacokinetics
- in vitro information for cytochromes P450
- other metabolic enzymes and transporters
- enzymes affected by inducers, inhibitors, and activators
The Drug Interaction Database displays the information contained in each article in an original format. The database thus provides both general and specific information ranging from the type of clinical study design or in vitro incubation conditions to measured in vitro Km and Ki values.
For more information: http://www.druginteractioninfo.org/
Licensing Information
Drug Interaction Database is one of the many software programs and tools created at the University of Washington available through our Express Licensing Program. These agreements have standard terms and conditions that allow for rapid licensing by companies, organizations, or individuals.
-
Education / Government License
-
License
Download the license (PDF file), sign it, and return it to the UW Center for Commercialization. The conditions and financial terms of this license apply only to those who sign and return it "as is.". Some Express Licenses may be modified for an additional cost.
This license references the Privacy Policy for the Drug Interaction Database.
-
Pharmaceutical Company License
-
License
Download the license (PDF file), sign it, and return it to the UW Center for Commercialization. The conditions and financial terms of this license apply only to those who sign and return it "as is.". Some Express Licenses may be modified for an additional cost.
This license references the Privacy Policy for the Drug Interaction Database.
Mergers & Acquisitions
Subscribers to the University of Washington’s Drug Interaction Database notify UW of mergers and acquisitions. It is UW’s policy that when the organizations that merge desire to maintain a subscription to the Database in the new merged entity, the following pricing will apply:
Provided the merger does not change any other terms in the Subscriber’s Agreement, upon the first renewal cycle where the organizations have merged, the license will receive a 25% discount from the price paid by the larger subscription agreement with UW.Example: An organization paying $52,500/year and an organization paying $21,000/year merge. Upon the next renewal period, the combined organization will receive a 25% discount from the $52,500 existing (larger fee) license, plus the $21,000 (smaller fee). Thus, the new merged entity will receive a $13,125/year discount for a NEW combined license fee of $60,375/year.
The conditions and financial terms of this license apply only to those who download the license, sign it and return it "as is" to the UW Center for Commercialization. Some Express Licenses may be modified for an additional cost. Other licensing arrangements may be available.
For Descriptive and Technical Information
For Licensing Information/Customer Service
UW Center for Commercialization
4311 11th Avenue NE, Suite 500
Seattle, WA 98105-4608
Phone: (206) 543-3970
Fax: (206) 616-3322
Email: license@u.washington.edu